Alzamend Neuro Stock Price Patterns
| ALZN Stock | USD 1.64 0.01 0.61% |
Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (2.52) | EPS Estimate Next Year (2.98) | Wall Street Target Price 28 | EPS Estimate Current Quarter (1.96) |
Using Alzamend Neuro hype-based prediction, you can estimate the value of Alzamend Neuro from the perspective of Alzamend Neuro response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Alzamend Neuro to buy its stock at a price that has no basis in reality. In that case, they are not buying Alzamend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Alzamend Neuro after-hype prediction price | USD 1.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections. Alzamend Neuro After-Hype Price Density Analysis
As far as predicting the price of Alzamend Neuro at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alzamend Neuro or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alzamend Neuro, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alzamend Neuro Estimiated After-Hype Price Volatility
In the context of predicting Alzamend Neuro's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alzamend Neuro's historical news coverage. Alzamend Neuro's after-hype downside and upside margins for the prediction period are 0.08 and 5.90, respectively. We have considered Alzamend Neuro's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alzamend Neuro is slightly risky at this time. Analysis and calculation of next after-hype price of Alzamend Neuro is based on 3 months time horizon.
Alzamend Neuro Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Alzamend Neuro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alzamend Neuro backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alzamend Neuro, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 4.29 | 0.02 | 0.03 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.64 | 1.61 | 1.23 |
|
Alzamend Neuro Hype Timeline
Alzamend Neuro is presently traded for 1.64. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.03. Alzamend is forecasted to decline in value after the next headline, with the price expected to drop to 1.61. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.23%, whereas the daily expected return is presently at -0.49%. The volatility of related hype on Alzamend Neuro is about 7032.79%, with the expected price after the next announcement by competition of 1.61. The company has price-to-book (P/B) ratio of 1.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. Alzamend Neuro recorded a loss per share of 2.67. The entity had not issued any dividends in recent years. The firm had 1:9 split on the 12th of May 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections.Alzamend Neuro Related Hype Analysis
Having access to credible news sources related to Alzamend Neuro's direct competition is more important than ever and may enhance your ability to predict Alzamend Neuro's future price movements. Getting to know how Alzamend Neuro's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alzamend Neuro may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCDA | Biocardia | 0.01 | 8 per month | 0.00 | (0.05) | 5.93 | (6.03) | 19.36 | |
| CELZ | Creative Medical Technology | (0.06) | 6 per month | 0.00 | (0.15) | 8.43 | (9.64) | 25.03 | |
| HCWB | HCW Biologics | (0.10) | 6 per month | 0.00 | (0.26) | 13.02 | (16.16) | 41.72 | |
| ACXP | Acurx Pharmaceuticals LLC | 0.01 | 4 per month | 0.00 | (0.19) | 9.45 | (8.06) | 49.19 | |
| APRE | Aprea Therapeutics | 0.01 | 8 per month | 0.00 | (0.14) | 4.44 | (10.58) | 46.26 | |
| ADIL | Adial Pharmaceuticals | (0.32) | 6 per month | 0.00 | (0.32) | 5.70 | (8.24) | 34.48 | |
| KPRX | Kiora Pharmaceuticals | 0.05 | 5 per month | 0.00 | (0.06) | 4.44 | (5.19) | 16.69 | |
| NRSN | Neurosense Therapeutics | 0.09 | 7 per month | 4.48 | 0.04 | 12.82 | (7.37) | 34.62 | |
| CDIO | Cardio Diagnostics Holdings | (0.23) | 22 per month | 0.00 | (0.19) | 14.54 | (13.93) | 38.04 | |
| PHIO | Phio Pharmaceuticals Corp | (0.07) | 7 per month | 4.42 | 0.03 | 7.34 | (7.53) | 29.87 |
Alzamend Neuro Additional Predictive Modules
Most predictive techniques to examine Alzamend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alzamend using various technical indicators. When you analyze Alzamend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Alzamend Neuro Predictive Indicators
The successful prediction of Alzamend Neuro stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alzamend Neuro, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alzamend Neuro based on analysis of Alzamend Neuro hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alzamend Neuro's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alzamend Neuro's related companies.
Pair Trading with Alzamend Neuro
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alzamend Neuro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will appreciate offsetting losses from the drop in the long position's value.Moving against Alzamend Stock
The ability to find closely correlated positions to Alzamend Neuro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alzamend Neuro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alzamend Neuro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alzamend Neuro to buy it.
The correlation of Alzamend Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alzamend Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alzamend Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alzamend Neuro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Biotechnology sector continue expanding? Could Alzamend diversify its offerings? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alzamend Neuro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alzamend Neuro's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alzamend Neuro represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alzamend Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.